Circulating FABP4 levels have been independently correlated with increased risk for CVDs, early prediction of myocardial infarction (25), poor prognosis following stroke (26), T2D (27), nonalcoholic fatty liver disease (28), worsened glycemic control in type 1 diabetes (29), diabetic complications including retinopathy and nephropathy (30), preeclampsia (31), and association with various cancers, including breast cancer (19) and leukemia (20). Here, FABP4 is linked to cancer.